| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.60▲ | 7.63▼ | 7.66▼ | 7.24▲ | 6.53▲ |
| MA10 | 7.61▲ | 7.65▼ | 7.60▲ | 6.78▲ | 6.38▲ |
| MA20 | 7.62▼ | 7.58▲ | 7.39▲ | 6.41▲ | 6.38▲ |
| MA50 | 7.64▼ | 7.23▲ | 6.97▲ | 6.25▲ | 7.41▲ |
| MA100 | 7.56▲ | 6.86▲ | 6.51▲ | 6.38▲ | 7.18▲ |
| MA200 | 7.24▲ | 6.45▲ | 6.28▲ | 7.55▲ | 9.06▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.020▼ | -0.003▼ | 0.168▲ | 0.151▲ |
| RSI | 48.121▼ | 60.269▲ | 66.478▲ | 72.941▲ | 57.886▲ |
| STOCH | 35.714 | 49.881 | 75.139 | 89.969▲ | 54.948 |
| WILL %R | -50.000 | -55.357 | -25.833 | -8.391▲ | -7.554▲ |
| CCI | -50.000 | -4.741 | 52.143 | 137.592▲ | 276.946▲ |
|
Friday, December 05, 2025 04:57 AM
Key Insights The considerable ownership by retail investors in Nuvectis Pharma indicates that they collectively have ...
|
|
Tuesday, November 25, 2025 12:00 AM
Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative precision ...
|
|
Monday, November 24, 2025 04:00 PM
Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative precision ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 7.58 | 7.7567 | 7.2639 | 7.59 | 76,325 |
| 11/12/25 | 7.39 | 7.66 | 7.17 | 7.58 | 100,000 |
| 10/12/25 | 6.925 | 7.41 | 6.92 | 7.39 | 138,819 |
| 09/12/25 | 6.60 | 7.23 | 6.47 | 6.99 | 186,000 |
| 08/12/25 | 6.79 | 6.83 | 6.54 | 6.65 | 74,161 |
| 05/12/25 | 6.78 | 6.84 | 6.60 | 6.71 | 104,300 |
| 04/12/25 | 6.39 | 6.79 | 6.39 | 6.745 | 131,435 |
| 03/12/25 | 5.84 | 6.50 | 5.81 | 6.38 | 99,700 |
| 02/12/25 | 5.985 | 5.985 | 5.77 | 5.81 | 69,510 |
| 01/12/25 | 6.24 | 6.3793 | 5.87 | 5.94 | 108,426 |
|
|
||||
|
|
||||
|
|